Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Pipotiazine→

Pipotiazine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
39860-99-6
Molecular formula
C24H33N3O3S2
Molecular weight
475.7 g/mol
Drug class
Long-acting phenothiazine antipsychoticdopamine-receptor antagonist
Mechanism of action
Blocks postsynaptic dopamine receptors, particularly D2-family receptors, and also interacts with serotonergic, histaminergic, adrenergic and muscarinic receptors. Depot formulations provide prolonged antipsychotic exposure.
Indications / reported uses
  • Maintenance treatment of schizophrenia and other chronic psychotic disorders with long-acting injectable formulations where authorised.

Sources: https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=62867 · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Pipotiazine Environmental Risk Assessment (ERA) (the Pipotiazine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.